Next Biomedical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2020
Cash & Equivalents	5,830	4,950	3,902	3,014	22,016	6,740	Upgrade
Short-Term Investments	13,133	20,766	10,388	11,783	-	-	Upgrade
Trading Asset Securities	22,494	15,892	-	-	-	-	Upgrade
Cash & Short-Term Investments	41,456	41,609	14,290	14,797	22,016	6,740	Upgrade
Cash Growth	190.11%	191.17%	-3.43%	-32.79%	226.66%	-39.94%	Upgrade
Accounts Receivable	2,133	1,845	918.64	314.3	118.67	104.03	Upgrade
Other Receivables	210.07	321.39	214.28	170.84	86.52	6.55	Upgrade
Receivables	2,343	2,167	1,133	485.15	205.19	110.58	Upgrade
Inventory	2,558	2,581	2,169	1,940	1,313	1,973	Upgrade
Prepaid Expenses	181.46	190.08	155.85	207.32	138.44	186.68	Upgrade
Other Current Assets	293.15	341.35	220.7	90.8	65.69	304.12	Upgrade
Total Current Assets	46,832	46,888	17,968	17,521	23,739	9,315	Upgrade
Property, Plant & Equipment	11,306	11,270	11,428	11,735	11,918	11,860	Upgrade
Long-Term Investments	-	-	-	2,637	3,737	3,088	Upgrade
Other Intangible Assets	318.04	344.38	217.63	222.19	288.71	288.99	Upgrade
Long-Term Accounts Receivable	0	-0	-0	-0	-0	0	Upgrade
Other Long-Term Assets	710.66	342.75	29.48	21.35	37.51	38.82	Upgrade
Total Assets	59,167	58,844	29,643	32,136	39,720	24,591	Upgrade
Accounts Payable	138.68	13.37	58.16	45.02	4.1	9.19	Upgrade
Accrued Expenses	146.47	126.23	121.14	106.93	96.48	91.11	Upgrade
Short-Term Debt	5,600	5,600	5,600	5,600	5,600	4,430	Upgrade
Current Portion of Long-Term Debt	4,439	4,539	4,897	4,800	5,200	5,600	Upgrade
Current Portion of Leases	23.42	26.37	41.51	35.6	32.24	37.92	Upgrade
Other Current Liabilities	1,815	1,579	714.37	452.97	2,115	28,503	Upgrade
Total Current Liabilities	12,163	11,884	11,433	11,041	13,048	38,671	Upgrade
Long-Term Debt	721.84	763.5	933.54	500	20,873	3,456	Upgrade
Long-Term Leases	16.25	20.58	46.9	81.63	46.55	39.96	Upgrade
Other Long-Term Liabilities	239.45	235.35	218.84	368.8	284.7	18,999	Upgrade
Total Liabilities	13,862	13,653	13,191	12,462	34,636	61,457	Upgrade
Common Stock	4,044	4,043	3,174	3,110	3,105	713.29	Upgrade
Additional Paid-In Capital	107,302	107,234	61,632	60,679	60,603	2,499	Upgrade
Retained Earnings	-70,613	-70,181	-72,984	-65,367	-59,673	-43,043	Upgrade
Comprehensive Income & Other	4,572	4,095	2,277	1,324	1,049	724.57	Upgrade
Total Common Equity	45,305	45,191	-5,901	-253.84	5,084	-39,106	Upgrade
Shareholders' Equity	45,305	45,191	16,452	19,674	5,084	-36,866	Upgrade
Total Liabilities & Equity	59,167	58,844	29,643	32,136	39,720	24,591	Upgrade
Total Debt	10,801	10,949	11,519	11,017	31,751	13,564	Upgrade
Net Cash (Debt)	30,655	30,659	2,771	3,780	-9,735	-6,824	Upgrade
Net Cash Growth	1006.49%	1006.61%	-26.70%	-	-	-	Upgrade
Net Cash Per Share	3914.10	4146.00	441.28	608.67	-2011.96	-1594.48	Upgrade
Filing Date Shares Outstanding	8.09	8.09	6.28	6.21	4.84	4.28	Upgrade
Total Common Shares Outstanding	8.09	8.09	6.28	6.21	4.84	4.28	Upgrade
Working Capital	34,669	35,004	6,536	6,480	10,691	-29,357	Upgrade
Book Value Per Share	5601.40	5588.37	-939.89	-40.88	1050.64	-9136.87	Upgrade
Tangible Book Value	44,987	44,847	-6,119	-476.03	4,795	-39,395	Upgrade
Tangible Book Value Per Share	5562.08	5545.78	-974.55	-76.65	990.97	-9204.39	Upgrade
Land	5,277	5,277	5,277	5,277	5,277	5,385	Upgrade
Buildings	5,786	5,786	5,786	5,786	5,786	5,044	Upgrade
Machinery	1,598	1,598	1,430	1,397	1,504	1,338	Upgrade
Construction In Progress	232.45	99.29	119.06	150.11	188.87	660.15	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.